¡°	generic famotidine	7.127029522247281
	tiotidine	6.357205262259373
¡°	specific compound famotidine	3.579156794313167
¡°	anti ulcer drug famotidine	2.9431526581857503
¡°	pharmacologically suitable H2 antagonist	1.622412789885523
	nizatidine.4 Famotidine	1.5934093650107093
	histamine2 antagonist	1.4877729138234372
	JMOL motion	1.4649237758331195
	invalidity certification	1.419489656425667
	FDCA	1.194775811717404
	substituted heterocycle group	1.0478481988002317
	paragraph IV ANDA filing	0.9045162320002947
	burimamide	0.7972671065866103
	metiamide	0.7972671065866103
	lupitidine	0.7972671065866103
	cimetidine,1	0.7972671065866103
	ANDA filer	0.5557963138148704
	hepatitis	0.45988474682982716
	Richard Owen	0.41420650310810525
	heartburn	0.3205818106522212
	Cosmetic	0.3205818106522212
	Patent Certification Notice Letter	0.24028055842965235
	certification letter	0.23722377282247495
	pre cancerous lesion	0.2309089790663827
	notable failure	0.230056948558182
	paragraph iv certification	0.22033971539094668
	baseless ANDA warrant award	0.2073017404923066
	paragraph IV certification	0.20513475409377757
	paragraph iii certification	0.19576234982895047
	paragraph II certification	0.19336343795647515
	Longi	0.1931464649855266
	rote application	0.16029112291017605
	speculation	0.15855912569652628
	gastric acid secretion	0.13512972174309215
	Drug Price Competition Patent Term Restoration Act	0.12729659474361552
	injectable version	0.1231856356140411
	prescription sale	0.12276281792857767
	paragraph IV anda	0.11975675765296696
	Colorado Found	0.11299728610099954
	Pub	0.10842289446900258
	potential weakness	0.10290580052798094
	inhibitor	0.09833907868959216
	Dillon	0.09833907868959216
	ANDA procedure	0.09728623768283594
	Hatch Waxman Act	0.0936434480794871
	Rouffet	0.0860002894583546
	FDA approval	0.08301871259795773
	award attorney fee	0.08051549519432334
	low toxicity	0.07606089633868737
	Drs	0.0674354465054728
	hereinafter	0.0674354465054728
	enough promise	0.06725200234160762
	prior art corollary	0.06439473284178143
	improved pharmacological property	0.06366430996923221
	adequate foundation	0.059882947893702076
	oral dosing	0.05752498622504561
	Merck	0.05734762076331433
	Rockwell Corp.	0.05682736998751819
	forty five day	0.04898193563556126
	critical safeguard	0.046070909999251876
	suitable compound	0.04566510505826292
	potential compound	0.04251775530694877
	previously approve drug	0.04218859478549613
	stomach acid	0.039667111131683086
	hundred thousand	0.03930943545205815
	generic drug	0.03772820118607238
	high activity	0.033102060714300316
	largely hindsight	0.03169457318028428
	chemical compound	0.03053559170039288
	drug manufacturer	0.030258848532066437
	willful infringement	0.029650342119171304
	Panduit Corp.	0.028666763415685012
	extraordinary property	0.028063086060226918
	white blood cell loss	0.027570674702933534
	motivation	0.026193609190034037
	absolute predictability	0.0252021163893535
	identification	0.024495051554960273
	specified date	0.022518595611586145
	Rader	0.021072631215468988
	various prior art compound	0.019871828750050908
	Abbreviated New Drug Application	0.018819139663524245
	Figure	0.017907897341358444
	hindsight analysis	0.016129238020691862
	district court JMOL finding	0.01522436846995711
	affidavit	0.0150037597421153
	Univ	0.01484610289822588
	Food Drug Administration	0.013675688284018727
	several critical factual underpinning	0.01353931490549214
	consumer use	0.011349975351973969
	chain	0.010536315607734494
	generic version	0.010173930135444886
	human clinical trial	0.009933645948812598
	New York	0.009800115261302625
	prima facie case	0.009586870757885575
	Southern District	0.0076315026775609805
	structural similarity	0.006502610932961904
	Federal Food	0.00633232503707807
	credibility	0.006320871240101215
	pharmaceutical company	0.005798326603645566
	research	0.005346677594259128
	reasonable expectation	0.005064953660296999
	Am	0.004605008297848483
	production	0.004301640753105263
	R.Civ	0.003603734299083466
	old element	0.003592567390160106
	success	0.0035697223918242653
	Rule	0.0032353398642558364
	general chemical structure	0.0031643858292264284
	select portion	0.0030363744665164445
	last witness	0.002682419044231253
	objective indicia	0.0023633517253951936
	virtually invention	0.002290618487160766
	obviousness construct	0.0022060312691769657
	Obviousness	0.0021897189806390923
	nonobviousness	0.0020817915269265162
	August	0.0017029212710652768
	deference	0.0015411683204795707
	discretion	0.001358152142047271
	side effect	0.0012779148895441235
	January	0.0008505871919899879
	owner	0.00084696260858192
	March	0.0008095501388851182
	composition	0.0007299063268796975
	P.	0.0006917605014273199
	requirement stand	0.0006887174699330106
	internal citation	0.0006265426678307312
	patentability	0.000624655427776082
	bench trial	0.0005456553655318984
	content	0.0004455366634914666
	cost	0.0004124556214273734
	asserted invalidity	0.00037363486720199865
	district judge	0.0003129955794870329
	combination	0.0002562228957944623
	defendant	0.00021746124885060653
	example	0.00020183939426746768
	validity dispute	0.00016861498087804871
	lack	0.00016724735736694057
	every element	0.000136392190924255
	level	0.00013332846957421463
	legal test	0.00011219275098565253
	follow four statement	9.310025260178713e-05
	underlie finding	6.723727416061434e-05
	skill	3.3005789328919636e-05
	favor	2.1722911333773755e-05
	two suit	1.6384536293362652e-05
	clear error	1.1606201812560236e-05
	scope	5.704603823633017e-07
	prior art subject matter	5.643189647838184e-07
	argument	3.987474701641385e-07
	evidence	1.753337029580128e-07
	prior art reference	1.675715932084393e-07
	law	9.1781294306378e-08
	party	9.165208536821238e-08
	infringement action	6.02646390986805e-08
	judgment	2.0588159213105508e-09
	issue	1.0511064954942951e-09
	Court	0.0
	Appeals	0.0
	Inc.	0.0
